{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:50:18Z","timestamp":1761058218451,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1378\/chest.127.2_suppl.27s","type":"journal-article","created":{"date-parts":[[2005,2,10]],"date-time":"2005-02-10T18:58:15Z","timestamp":1108061895000},"page":"27S-34S","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"S","title":["Transition to an Oral Anticoagulant in Patients With Heparin-Induced Thrombocytopenia"],"prefix":"10.1016","volume":"127","author":[{"given":"John R","family":"Bartholomew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.127.2_suppl.27S_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-126-2-199701150-00006","article-title":"Comparison of 5 mg and 10 mg loading doses in initiation of warfarin therapy","volume":"126","author":"Harrison","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.127.2_suppl.27S_bib2","doi-asserted-by":"crossref","first-page":"804","DOI":"10.7326\/0003-4819-127-9-199711010-00005","article-title":"The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia","volume":"127","author":"Warkentin","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.127.2_suppl.27S_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1096-8652(199909)62:1<44::AID-AJH7>3.0.CO;2-F","article-title":"Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia","volume":"62","author":"Warkentin","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1378\/chest.127.2_suppl.27S_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archinte.164.1.66","article-title":"Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia","volume":"164","author":"Srinivasan","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.127.2_suppl.27S_bib5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-135-7-200110020-00009","article-title":"Delayed-onset heparin-induced thrombocytopenia and thrombosis","volume":"135","author":"Warkentin","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.127.2_suppl.27S_bib6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7326\/0003-4819-136-3-200202050-00009","article-title":"Delayed-onset heparin-induced thrombocytopenia","volume":"136","author":"Rice","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.127.2_suppl.27S_bib7","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(96)00258-6","article-title":"A 14-year study of heparin-induced thrombocytopenia","volume":"101","author":"Warkentin","year":"1996","journal-title":"Am J Med"},{"key":"10.1378\/chest.127.2_suppl.27S_bib8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0002-9343(99)00124-2","article-title":"Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia","volume":"106","author":"Wallis","year":"1999","journal-title":"Am J Med"},{"key":"10.1378\/chest.127.2_suppl.27S_bib9","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archinte.163.15.1849","article-title":"Argatroban anticoagulation in patients with heparin-induced thrombocytopenia","volume":"163","author":"Lewis","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.127.2_suppl.27S_bib10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.7326\/0003-4819-127-9-199711010-00012","article-title":"Thrombotic complications of antithrombotic therapy: a paradox with implications for clinical practice","volume":"127","author":"Raskob","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.127.2_suppl.27S_bib11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1365-2168.2000.01352.x","article-title":"Warfarin-induced skin necrosis","volume":"87","author":"Chan","year":"2000","journal-title":"Br J Surg"},{"key":"10.1378\/chest.127.2_suppl.27S_bib12","first-page":"271","article-title":"Coumarin necrosis: a review of the literature","volume":"103","author":"Cole","year":"1988","journal-title":"Surgery"},{"key":"10.1378\/chest.127.2_suppl.27S_bib13","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0889-8588(18)30209-0","article-title":"Warfarin-induced skin necrosis","volume":"7","author":"Eby","year":"1993","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1378\/chest.127.2_suppl.27S_bib14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1055\/s-0038-1657628","article-title":"Warfarin and heparin-induced skin necrosis and the purple toe syndrome: infrequent complications of anticoagulant treatment","volume":"78","author":"Sallah","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.127.2_suppl.27S_bib15","first-page":"1121","article-title":"Thrombophlebitis migrans disseminata: report of a case in which gangrene of the breast occurred","volume":"43","author":"Flood","year":"1943","journal-title":"NY State J Med"},{"key":"10.1378\/chest.127.2_suppl.27S_bib16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.0954-6820.1954.tb01741.x","article-title":"Local haemorrhage and necrosis of the skin and underlying tissues, during anti-coagulant therapy with dicumarol or dicumacyl","volume":"148","author":"Verhagen","year":"1954","journal-title":"Acta Med Scand"},{"key":"10.1378\/chest.127.2_suppl.27S_bib17","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1182\/blood.V96.3.846","article-title":"Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTTT range","volume":"96","author":"Greinacher","year":"2000","journal-title":"Blood"},{"key":"10.1378\/chest.127.2_suppl.27S_bib18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1177\/000331978803901009","article-title":"Coumarin skin necrosis in a patient with heparin-induced thrombocytopenia-a case report","volume":"39","author":"Celoria","year":"1988","journal-title":"Angiology"},{"key":"10.1378\/chest.127.2_suppl.27S_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/bmj.307.6895.53","article-title":"Heparin-induced thrombocytopenia: an important complication of heparin prophylaxis for thromboembolic disease in surgery","volume":"307","author":"Hunter","year":"1993","journal-title":"BMJ"},{"key":"10.1378\/chest.127.2_suppl.27S_bib20","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/000331979604700715","article-title":"Coumarin-induced skin necrosis following heparin-induced thrombocytopenia and thrombosis","volume":"47","author":"Shahak","year":"1996","journal-title":"Angiology"},{"key":"10.1378\/chest.127.2_suppl.27S_bib21","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1378\/chest.102.5.1578-b","article-title":"Thrombocytopenia, cutaneous necrosis, and gangrene of the upper and lower extremities in a 35 year old man","volume":"102","author":"Thomas","year":"1992","journal-title":"Chest"},{"key":"10.1378\/chest.127.2_suppl.27S_bib22","first-page":"259","article-title":"Successful administration of low molecular weight heparin in a patient with heparin-induced thrombocytopenia and coumarin-induced skin necrosis","volume":"23","author":"Drakos","year":"1993","journal-title":"Haemostasis"},{"key":"10.1378\/chest.127.2_suppl.27S_bib23","doi-asserted-by":"crossref","first-page":"589","DOI":"10.7326\/0003-4819-135-8_Part_1-200110160-00009","article-title":"Venous limb gangrene during warfarin treatment of cancer-associated deep venous thrombosis","volume":"135","author":"Warkentin","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.127.2_suppl.27S_bib24","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1001\/archderm.139.9.1126","article-title":"Paradoxical venous limb gangrene complicating oral anticoagulation in a patient with cancer-associated deep venous thrombosis","volume":"139","author":"Georgin","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1378\/chest.127.2_suppl.27S_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ajh.10181","article-title":"Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia","volume":"71","author":"Smythe","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1378\/chest.127.2_suppl.27S_bib26","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1001\/archsurg.1979.01370280026004","article-title":"White clot syndrome: peripheral vascular complications of heparin therapy","volume":"114","author":"Towne","year":"1979","journal-title":"Arch Surg"},{"key":"10.1378\/chest.127.2_suppl.27S_bib27","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1378\/chest.116.5.1333","article-title":"Safety of warfarin anticoagulation in patients with heparin-induced thrombocytopenia","volume":"116","author":"Wallis","year":"1999","journal-title":"Chest"},{"key":"10.1378\/chest.127.2_suppl.27S_bib28","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1056\/NEJM198010163031602","article-title":"Heparin-associated thrombocytopenia: a comparison of three heparin preparations","volume":"303","author":"Bell","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.127.2_suppl.27S_bib29","first-page":"763","article-title":"The heparin-induced thrombocytopenia syndrome: an update","volume":"102","author":"Laster","year":"1987","journal-title":"Surgery"},{"key":"10.1378\/chest.127.2_suppl.27S_bib30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00001721-199507000-00001","article-title":"Warfarin-induced changes in procoagulant and anticoagulant proteins","volume":"6","author":"Stirling","year":"1995","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1378\/chest.127.2_suppl.27S_bib31","unstructured":"Greenberg CS, Orthner CL. Blood coagulation and fibrinolysis.In: Wintrobe's clinical hematology. Baltimore MD: Lippincott Williams & Williams, 1999; 694 \u2013 695"},{"key":"10.1378\/chest.127.2_suppl.27S_bib32","first-page":"14F","article-title":"Treatment of heparin-induced thrombocytopenia: a critical review","volume":"12","author":"Hirsh","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.127.2_suppl.27S_bib33","first-page":"14F","article-title":"Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention","volume":"12","author":"Campbell","year":"2000","journal-title":"J Invasive Cardiol"},{"issue":"suppl 1","key":"10.1378\/chest.127.2_suppl.27S_bib34","first-page":"P1909","article-title":"Bivalirudin, a direct thrombin inhibitor, in the treatment of heparin-induced thrombocytopenia [abstract]","author":"Francis","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"suppl 100","key":"10.1378\/chest.127.2_suppl.27S_bib35","first-page":"130b","article-title":"The magnitude of protime INR effect by the direct thrombin inhibitor lepirudin in patients with heparin-induced thrombocytopenia [abstract]","author":"Nguyen","year":"2002","journal-title":"Blood"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215308175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215308175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:42:38Z","timestamp":1757918558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215308175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0012369215308175"],"URL":"https:\/\/doi.org\/10.1378\/chest.127.2_suppl.27s","relation":{},"ISSN":["0012-3692"],"issn-type":[{"type":"print","value":"0012-3692"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transition to an Oral Anticoagulant in Patients With Heparin-Induced Thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.127.2_suppl.27S","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}